Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Symanska, Kazia
DOB:	04-MAR-1952 (Age: 73)
Gender:	female
Address:	ul. Celna 102 70-644 Szczecin (Poland)
ID:	4349-062082-0

Report
Date:	16-MAY-2025

Laboratory
dr Ample, Ex Boulevard du Jardin Botanique 32 1000 Brussels

Requested by
4: Radioterapia, Komisja onkologiczna 70-560 Szczecin (Poland)

Specimen
Collected:	15-MAY-2025

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Hematology

Test	15 May 2025	Reference Range	Unit
Leukocytes [#/volume] in Blood by Automated count	10.1	3.4 - 10.6	10*3/uL
Erythrocytes [#/volume] in Blood by Automated count	5.2	4.2 - 5.8	10*6/uL
Hemoglobin [Mass/volume] in Blood	13.0	12 - 16	g/dL
Hematocrit [Volume Fraction] of Blood by Automated count	41.9	35 - 52	%
MCV [Entitic volume] by Automated count	80.4	80 - 100	fL
MCH [Entitic mass] by Automated count	32.9	27.5 - 34.5	pg
MCHC [Mass/volume] by Automated count	35.1	32 - 37	g/dL
Erythrocyte distribution width [Entitic volume] by Automated count	44.5	36 - 55	fL
Platelets [#/volume] in Blood by Automated count	241.0	150 - 450	10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count	334.4 H	13.4 - 17.4	fL
Platelet mean volume [Entitic volume] in Blood by Automated count	10.9	7.2 - 13.8	fL

Chemistry

Test	15 May 2025	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	5.8	4 - 6.4	%
Glucose [Mass/volume] in Blood	68.0 L	70 - 99	mg/dL
Urea nitrogen [Mass/volume] in Blood	9.9	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	0.6	0.5 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	9.1	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	140.4	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	3.8	3.5 - 5	mmol/L
Chloride [Moles/volume] in Blood	110.5 H	98 - 108	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	24.4	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	188.7	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	125.3	35 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	99.9	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	63.8	50 - 100	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	4.4	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Laboratory results show stable metabolic and renal function, good glycemic control, and favorable lipid profile. Mild, persistent hyperchloremia and a recent isolated low fasting glucose are noted. Platelet distribution width is elevated, which may warrant correlation with clinical findings. No evidence of significant proteinuria or renal impairment. Overall, no acute laboratory concerns; recommend continued routine monitoring.

Conclusion and Recommendations based on this report and previous findings known to us

Laboratory results show stable metabolic and renal function, good glycemic control, and favorable lipid profile. Mild, persistent hyperchloremia and a recent isolated low fasting glucose are noted. Platelet distribution width is elevated, which may warrant correlation with clinical findings. No evidence of significant proteinuria or renal impairment. Overall, no acute laboratory concerns; recommend continued routine monitoring.